Harnessing the nutriceutics in early-stage breast cancer: mechanisms, combinational therapy, and drug delivery - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39294665/
The present review provides a comprehensive understanding of the molecular mechanisms, coupled with well-designed clinical trials and adherence to regulatory guidelines, which pave the way for nutrition-based combination therapies to...
This review highlights the potential of dietary phytomolecules in breast cancer treatment, focusing on their molecular mechanisms, combination therapy, novel drug delivery systems, and regulatory considerations for clinical application.
Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: a randomized controlled trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38773552/
Clinicaltrials.gov: NCT04144309. Registered 12 June 2018.
This randomized trial found that infrared laser moxibustion (ILM) significantly reduced cancer-related fatigue in breast cancer survivors compared to a waitlist control, with promising but inconclusive results versus sham treatment.
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38391750/
Paraneoplastic neurological syndromes (PNSs) are an uncommon complication of cancer, affecting nearby 1/10,000 subjects with a tumour. PNSs can involve all the central and peripheral nervous systems, the muscular system,...
This case report discusses a young female with paraneoplastic cerebellar degeneration and seronegative rigid syndrome linked to infiltrating ductal carcinoma of the breast, highlighting the importance of early diagnosis and treatment.
Present and Future of Immunotherapy for Triple-Negative Breast Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39409871/
Triple-negative breast cancer (TNBC) lacks the expression of estrogen receptors (ERs), human epidermal growth factor receptor 2 (HER2), and progesterone receptors (PRs). TNBC has the poorest prognosis among breast cancer...
Triple-negative breast cancer (TNBC) lacks ER, HER2, and PR expression, making it difficult to treat. Immunotherapy, especially pembrolizumab with chemotherapy, shows promise, but combination strategies may enhance response rates and outcomes.
Advanced Hydrogels in Breast Cancer Therapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39057502/
Breast cancer is the most common malignancy among women and is the second leading cause of cancer-related death for women. Depending on the tumor grade and stage, breast cancer is...
This review summarizes recent advancements in hydrogel-based therapies for breast cancer, including tissue reconstruction, tumor modeling, and controlled drug delivery, while addressing challenges in clinical translation.